Thibaut; Hendrik Jan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thibaut; Hendrik Jan.The latest application filed is for "novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient".

Company Profile

0.10.9

Thibaut; Hendrik Jan - Bierbeek BE
Thibaut; Hendrik Jan - Belgium BE
Thibaut; Hendrik Jan - Leuven BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient Grant 9,951,058 - Jung , et al. April 24, 2	2018-04-24
Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases Grant 9,890,133 - Jung , et al. February 13, 2	2018-02-13
1,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient Grant 9,833,423 - Jung , et al. December 5, 2	2017-12-05
Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient Grant 9,790,197 - Jung , et al. October 17, 2	2017-10-17
Novel Compound, Pharmaceutically Acceptable Salt Or Optical Isomer Thereof, Method For Preparing The Same, And Pharmaceutical Composition For Prevention Or Treatment Of Viral Diseases Containing Same As Active Ingredient App 20170158684 - Jung; Young Sik ; et al.	2017-06-08
Indanone Derivatives, Pharmaceutically Acceptable Salts Or Optical Isomers Thereof, Preparation Method For Same, And Pharmaceutical Compositions Containing Same As Active Ingredient For Preventing Or Treating Viral Diseases App 20160297789 - JUNG; Young Sik ; et al.	2016-10-13
Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases Grant 9,464,067 - Jung , et al. October 11, 2	2016-10-11
1,3-di-oxo-indene Derivative, Pharmaceutically Acceptable Salt Or Optical Isomer Thereof, Preparation Method Thereof, And Pharmaceutical Composition Containing Same As An Antiviral, Active Ingredient App 20160272564 - JUNG; Young Sik ; et al.	2016-09-22
1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient Grant 9,346,749 - Jung , et al. May 24, 2	2016-05-24
Compound for the Treatment of Enteroviruses App 20150030563 - NEYTS; Johan ; et al.	2015-01-29
Compound for the treatment of enteroviruses Grant 8,796,273 - Neyts , et al. August 5, 2	2014-08-05
1,3-di-oxo-indene Derivative, Pharmaceutically Acceptable Salt Or Optical Isomer Thereof, Preparation Method Thereof, And Pharmaceutical Composition Containing Same As An Antiviral, Active Ingredient App 20140121187 - Jung; Young Sik ; et al.	2014-05-01
Indanone Derivatives, Pharmaceutically Acceptable Salts Or Optical Isomers Thereof, Preparation Method For Same, And Pharmaceutical Compositions Containing Same As Active Ingredient For Preventing Or Treating Viral Diseases App 20140114068 - Jung; Young Sik ; et al.	2014-04-24
Compound For The Treatment Of Enteroviruses App 20120022073 - Neyts; Johan ; et al.	2012-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.